NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Belief BioMed Inc.

Belief BioMed Inc.

Private
ShanghaiHealthcare & Life Scienceshttps://www.beliefbiomed.com/

Last Round

Series B

Mar 1, 2022

Total Funding Raised

$250.45M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Belief BioMed Inc. is a biotechnology company that develops, manufactures, and commercializes adeno-associated virus (AAV) based gene therapies for genetic and chronic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

gene therapyAAVadeno-associated virushemophilia ADuchenne muscular dystrophygenetic medicinebiotechgene deliveryrare diseaseclinical-stage biotechvector platformbiopharmaceutical R&Dprecision medicineDMDdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Belief BioMed Inc. Comparables

Compare Belief BioMed Inc. with similar companies based on industry and business-model similarity.

Belief BioMed Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ASC Therapeutics
80%
Frontera Therapeutics
79%
Sangamo Therapeutics Inc
77%

Belief BioMed Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 1, 2022
Series BDec 1, 2020
Series AFeb 1, 2020
AngelNov 1, 2018
AngelJun 19, 2018

Key People

Founding team and executive leadership

Jane Zheng

Co-founder CEO

Founding Team

Vivian Ni

CEO EA PR AD

Executive Team

Belief BioMed Inc. Investors

Notable investors and investment history

Belief BioMed Inc. investors
InvestorRounds
MatrixSeries B
Northern Light Venture CapitalAngel, Series A
Cenova CapitalSeries B
MPCSeries B
CDG CapitalSeries B
Lilly Asia VenturesSeries B
Sherpa Healthcare PartnersAngel, Series B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 27, 2026

    Signed agreement for hemophilia A gene therapy in Greater China.

  • Mar 27, 2026

    Exclusive agreement with Grand Life Sciences Group for Greater China.

Belief BioMed Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Belief BioMed Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Belief BioMed Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range21
Year Founded2016
Last FundingMar 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.